Early human herpes virus type 6 reactivation in umbilical cord blood allogeneic stem cell transplantation

References

• Zerr DM, Meier AS, Selke SS, et al. A population-based study of primary human herpesvirus 6 infection. N Engl J Med. 2005;352:768–776.
   PubMed Web of Science ®Google Scholar
• Pichereau C, Desseaux K, Janin A, et al. The complex relationship between human herpesvirus 6 and acute graft-versus-host disease. Biol Blood Marrow Transplant. 2012;18:141–144.
   PubMed Web of Science ®Google Scholar
• Yoshikawa T, Asano Y, Ihira M, et al. Human herpesvirus 6 viremia in bone marrow transplant recipients: clinical features and risk factors. J Infect Dis. 2002;185:847–853.
   PubMed Web of Science ®Google Scholar
• Ogata M, Kikuchi H, Satou T, et al. Human herpesvirus 6 DNA in plasma after allogeneic stem cell transplantation: incidence and clinical significance. J Infect Dis. 2006;193:68–79.
   PubMed Web of Science ®Google Scholar
• Zerr DM, Corey L, Kim HW, et al. Clinical outcomes of human herpesvirus 6 reactivation after hematopoietic stem cell transplantation. Clin Infect Dis. 2005;40:932–940.
   PubMed Web of Science ®Google Scholar
• Gotoh M, Yoshizawa S, Katagiri S, et al. Human herpesvirus 6 reactivation on the 30th day after allogeneic hematopoietic stem cell transplantation can predict grade 2-4 acute graft-versus-host disease. Transpl Infect Dis. 2014;16:440–449.
   PubMed Web of Science ®Google Scholar
• de Pagter PJ, Schuurman R, Keukens L, et al. Human herpes virus 6 reactivation: important predictor for poor outcome after myeloablative, but not non-myeloablative allo-SCT. Bone Marrow Transplant. 2013;48:1460–1464.
   PubMed Web of Science ®Google Scholar
• Sashihara J, Tanaka-Taya K, Tanaka S, et al. High incidence of human herpesvirus 6 infection with a high viral load in cord blood stem cell transplant recipients. Blood. 2002;100:2005–2011.
   PubMed Web of Science ®Google Scholar
• Jeulin H, Agrinier N, Guery M, et al. Human herpesvirus 6 infection after allogeneic stem cell transplantation: incidence, outcome, and factors associated with HHV-6 reactivation. Transplantation. 2013;95:1292–1298.
   PubMed Web of Science ®Google Scholar
• Betts BC, Young JA, Ustun C, et al. Human herpesvirus 6 infection after hematopoietic cell transplantation: is routine surveillance necessary? Biol Blood Marrow Transplant. 2011;17:1562–1568.
   PubMed Web of Science ®Google Scholar
• Scheurer ME, Pritchett JC, Amirian ES, et al. HHV-6 encephalitis in umbilical cord blood transplantation: a systematic review and meta-analysis. Bone Marrow Transplant. 2013;48:574–580.
   PubMed Web of Science ®Google Scholar
• Yamane A, Mori T, Suzuki S, et al. Risk factors for developing human herpesvirus 6 (HHV-6) reactivation after allogeneic hematopoietic stem cell transplantation and its association with central nervous system disorders. Biol Blood Marrow Transplant. 2007;13:100–106.
   PubMed Web of Science ®Google Scholar
• Radonic A, Oswald O, Thulke S, et al. Infections with human herpesvirus 6 variant B delay platelet engraftment after allogeneic haematopoietic stem cell transplantation. Br J Haematol. 2005;131:480–482.
   PubMed Web of Science ®Google Scholar
• Carrigan DR, Knox KK. Human herpesvirus 6 (HHV-6) isolation from bone marrow: HHV-6-associated bone marrow suppression in bone marrow transplant patients. Blood. 1994;84:3307–3310.
   PubMed Web of Science ®Google Scholar
• Cone RW, Hackman RC, Huang ML, et al. Human herpesvirus 6 in lung tissue from patients with pneumonitis after bone marrow transplantation. N Engl J Med. 1993;329:156–161.
   PubMed Web of Science ®Google Scholar
• Dulery R, Salleron J, Dewilde A, et al. Early human herpesvirus type 6 reactivation after allogeneic stem cell transplantation: a large-scale clinical study. Biol Blood Marrow Transplant. 2012;18:1080–1089.
   PubMed Web of Science ®Google Scholar
• Zerr DM, Boeckh M, Delaney C, et al. HHV-6 reactivation and associated sequelae after hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2012;18:1700–1708.
   PubMed Web of Science ®Google Scholar
• Hentrich M, Oruzio D, Jager G, et al. Impact of human herpesvirus-6 after haematopoietic stem cell transplantation. Br J Haematol. 2005;128:66–72.
   PubMed Web of Science ®Google Scholar
• Kadakia MP, Rybka WB, Stewart JA, et al. Human herpesvirus 6: infection and disease following autologous and allogeneic bone marrow transplantation. Blood. 1996;87:5341–5354.
   PubMed Web of Science ®Google Scholar
• Takemoto Y, Takatsuka H, Wada H, et al. Evaluation of CMV/human herpes virus-6 positivity in bronchoalveolar lavage fluids as early detection of acute GVHD following BMT: evidence of a significant relationship. Bone Marrow Transplant. 2000;26:77–81.
   PubMed Web of Science ®Google Scholar
• Imbert-Marcille BM, Tang XW, Lepelletier D, et al. Human herpesvirus 6 infection after autologous or allogeneic stem cell transplantation: a single-center prospective longitudinal study of 92 patients. Clin Infect Dis. 2000;31:881–886.
   PubMed Web of Science ®Google Scholar
• Liu H, Rich ES, Godley L, et al. Reduced-intensity conditioning with combined haploidentical and cord blood transplantation results in rapid engraftment, low GVHD, and durable remissions. Blood. 2011;118:6438–6445.
   PubMed Web of Science ®Google Scholar
• Kline J, Pollyea DA, Stock W, et al. Pre-transplant ganciclovir and post transplant high-dose valacyclovir reduce CMV infections after alemtuzumab-based conditioning. Bone Marrow Transplant. 2006;37:307–310.
   PubMed Web of Science ®Google Scholar
• ASBMT RFI 2015 - Disease Classifications Corresponding to CIBMTR Classifications. 2015. Arlington Heights, IL: American Society of Blood and Marrow Transplantation. Available from: http://c.ymcdn.com/sites/www.asbmt.org/resource/resmgr/RFI/RFI_2015_-_CIBMTR_Disease_Cl.pdf.
   Google Scholar
• Przepiorka D, Weisdorf D, Martin P, et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant. 1995;15:825–828.
   PubMed Web of Science ®Google Scholar
• Jason PF, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Amer Statist Assoc. 1999;94:496–509.
   Web of Science ®Google Scholar